H2 Pipeline Review Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor Or Vanilloid Receptor 1 Or TRPV1) – 2017

DUBLIN--(BUSINESS WIRE)--

Research and Markets has announced the addition of the "Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) - Pipeline Review, H2 2016" report to their offering.

The report provides comprehensive information on the Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1), targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) targeted therapeutics development and features dormant and discontinued projects.

Key Topics Covered:

  1. Introduction
  2. Transient Receptor Potential Cation Channel Subfamily V Member 1 Overview
  3. Therapeutics Development
  4. Pipeline Products for Transient Receptor Potential Cation Channel Subfamily V Member 1 - Overview
  5. Pipeline Products for Transient Receptor Potential Cation Channel Subfamily V Member 1 - Comparative Analysis
  6. Transient Receptor Potential Cation Channel Subfamily V Member 1 - Therapeutics under Development by Companies
  7. Transient Receptor Potential Cation Channel Subfamily V Member 1 - Therapeutics under Investigation by Universities/Institutes
  8. Transient Receptor Potential Cation Channel Subfamily V Member 1 Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Transient Receptor Potential Cation Channel Subfamily V Member 1 - Products under Development by Companies
  13. Transient Receptor Potential Cation Channel Subfamily V Member 1 - Products under Investigation by Universities/Institutes
  14. Transient Receptor Potential Cation Channel Subfamily V Member 1 - Companies Involved in Therapeutics Development
  • Amgen Inc.
  • Amorepacific Corporation
  • AnaBios Corporation
  • Centrexion Therapeutics Corp
  • Daewoong Pharmaceutical Co., Ltd.
  • DoNatur GmbH
  • Flex Pharma, Inc.
  • Grunenthal GmbH
  • Kyowa Hakko Kirin Co., Ltd.
  • Medifron DBT Co., Ltd.
  • Neurim Pharmaceuticals Ltd
  • PharmEste
  • Pila Pharma AB
  • Sylentis S.A.U.
  • Toray Industries, Inc.

For more information about this report visit http://www.researchandmarkets.com/research/v6s46b/transient.

Source : http://www.businesswire.com/news/home/20161212005679/en/Transient-Receptor-Potential-Cation-Channel-Subfamily-Member

Here you can find information about how to track lost phone with imei number

Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) - Pipeline Review, H2 2016 - Research and Markets
Management of refractory typical GERD symptoms
[LIMITED STOCK!] Related eBay Products